Carboplatin and Paclitaxel in Metastatic or Recurrent Cervical Cancer-Reference-Cited by-同舟云学术

Carboplatin and Paclitaxel in Metastatic or Recurrent Cervical Cancer

Published:2009-05 Issue:4 Volume:19 Page:777-781
ISSN:1048-891X
Container-title:International Journal of Gynecological Cancer
language:en
Short-container-title:International Journal of Gynecological Cancer

Author:

Pectasides Dimitrios,Fountzilas George,Papaxoinis George,Pectasides Eirini,Xiros Nicolaos,Sykiotis Constantinos,Koumarianou Anna,Psyrri Amanda,Panayiotides John,Economopoulos Theofanis

Publisher

BMJ

Subject

Obstetrics and Gynecology,Oncology

Reference25 articles.

1. Global Cancer Statistics, 2002

2. Cancer Statistics, 2007

3. Phase III Study of Cisplatin With or Without Paclitaxel in Stage IVB, Recurrent, or Persistent Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study

4. Cis-platinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix: A phase ii study of the gynecologic oncology group

5. Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group study.

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reirradiation for recurrent gynecologic cancer using high-dose-rate brachytherapy in Japan: A multicenter survey on practice patterns and outcomes;Radiotherapy and Oncology;2024-06

2. Cervical Cancer;Tata Memorial Centre Textbook of Oncology;2024

3. Prognostic impact of adding bevacizumab to carboplatin and paclitaxel for recurrent, persistent, or metastatic cervical cancer;Taiwanese Journal of Obstetrics and Gynecology;2022-09

4. Ferroptosis: A New Road towards Cancer Management;Molecules;2022-03-25

5. A Rare Case of Squamous Cell Carcinoma of the Cervix With Incisional Site Recurrence;Cureus;2022-01-20